Professional Documents
Culture Documents
DeGroot Et Al. - 2001 - Accumulation of Advanced Glycation Endproducts Reduces Chondrocyte-Mediated Extracellular Matrix Turnover in Hum
DeGroot Et Al. - 2001 - Accumulation of Advanced Glycation Endproducts Reduces Chondrocyte-Mediated Extracellular Matrix Turnover in Hum
Summary
Objective: The prevalence of osteoarthritis (OAs) increases with age and coincides with the accumulation of advanced glycation endproducts
(AGEs) in articular cartilage, suggesting that accumulation of glycation products may be involved in the development of OA. This study was
designed to examine the effects of accumulation of AGEs on the turnover of the extracellular matrix of human articular cartilage.
Design: Chondrocyte mediated cartilage degradation (GAG release, colorimetric) was measured in human articular cartilage of donors aged
19–82 years (N=30, 4-day culture). In addition, to mimic the age-related increase in AGE levels in vitro, cartilage was cultured in the absence
or presence of glucose, ribose or threose. Cartilage degradation and proteoglycan synthesis (35SO2− 4 incorporation) were measured and
related to the degree of cartilage AGE levels (fluorescence at 360/460 nm).
Results: Chondrocyte-mediated degradation of articular cartilage (i.e. GAG release) decreased with increasing age of the cartilage donor
(r= −0.43, P<0.02). In vitro incubation of cartilage with glucose, ribose or threose resulted in a range of AGE levels that was highly correlated
to the chondrocyte-mediated cartilage degradation (r= −0.77, P<0.001, N=26). In addition, in these in vitro glycated cartilage samples, a
decrease in proteoglycan synthesis was observed at increasing AGE levels (r= −0.54, P<0.005, N=25).
Conclusions: This study shows that an increase in AGE levels negatively affects the proteoglycan synthesis and degradation of articular
cartilage. In combination, these two effects reduce the turnover of the cartilage and thereby the maintenance and repair capacity of the
tissue. By this mechanism, the age-related increase in cartilage AGE levels may contribute to the development of OA. © 2001 OsteoArthritis
Research Society International
Key words: Cartilage, Advanced glycation endproducts, Aging, Turnover, Proteoglycan degradation.
720
Osteoarthritis and Cartilage Vol. 9, No. 8 721
the synthesis of matrix components. AGE-modified albumin qualitative range of AGE levels, mimicking the diversity of
has been reported to stimulate collagen type IV synthesis in AGE found in vivo29,30.
glomerular mesangial cells21,22. In contrast, mesangial
cells grown in the presence of glycating sugars or on
glycated matrix show decreased synthesis of collagen AGE MEASUREMENTS
types I and IV23. Type I collagen synthesis is also inhibited
in endothelial cells and in fibroblast cell lines upon AGEs form a heterogenous group of compounds
exposure to glycated albumin24,25. that include structurally characterized structures (e.g.
The combined effects of AGEs on synthesis and pentosidine) as well as chemically unidentified compounds.
degradation of matrix constituents indicate that extracellu- Accumulation of AGEs has repeatedly been shown to result
lar matrix turnover (i.e. matrix synthesis and degradation) is in an increase in protein-bound fluorescence and
affected by AGEs. Since articular cartilage is one of the browning18,31–33. Therefore, to measure the overall level
tissues containing the highest amounts of AGEs in the of cartilage glycation rather than focusing on one of the
body, AGE-related effects on extracellular matrix turnover few characterized AGEs, cartilage AGE-fluorescence and
are likely to be of major importance in this tissue7,10,11,26. browning were determined using previously described
Therefore, the present study was designed to investigate methods11,32,33. Cartilage samples (three samples per
the relation between AGE levels and chondrocyte- condition per donor) were reduced overnight, sequentially
mediated turnover of proteoglycans in human articular treated with chondroitinase ABC (Sigma), trypsin
cartilage. (Boehringer Mannheim) and Streptomyces hyaluronidase
(Sigma), and solubilized by digestion with papain. In papain
digests, AGE specific absorption at 340 and 414 nm
(Titertek Multiskan MCC/340) and fluorescence (ex:
Experimental 360 nm, em: 460 nm; CytofluorII, PerSeptive Biosystems)
CARTILAGE SAMPLES
were determined11. Modification of the amino acids
arginine and (hydroxy)lysine was determined in acid hydro-
Macroscopically normal cartilage was obtained from lysates (6 N HCl, 18 h, 110°C) of the papain-digested
femoral condyles (N=30; 19–82 years) and humeral heads cartilage samples by RP-HPLC of 9-fluorenylmethyl chloro-
(N=7; 46–64 years) post mortem at autopsy within 24 h formate derivatized amino acids, as described previously34.
after death of the donors. Previous studies have shown NEG parameters were expressed per amount of hydro-
that this cartilage is biochemically normal, even if focal xyproline (absorption and fluorescence) or per collagen
OA lesions are present elsewhere in the joint27. Full thick- triple helix (amino acid modification; assuming 300
ness cartilage was cut into square pieces (5–15 mg), which hydroxyproline residues per triple helix)35.
were randomly divided over experimental conditions and
that were all individually handled. The cartilage explants
were cultured in Dulbecco’s Modified Eagle’s Medium PROTEOGLYCAN RELEASE
(GibcoBRL) supplemented with 0.85 mM ascorbic acid
(Sigma), 2 mM glutamin (GibcoBRL), 100 IU/ml sodium Cartilage degradation (N=9 samples per donor per
benzylpenicillin, 100 IU/ml streptomycin sulfate and 10% condition) was assessed by colorimetric assessment of
(v/v) heat inactivated adult pooled human male AB + serum glycosaminoglycan (GAG) release into the culture
(200 l/well, 37°C, 5% CO2 in air)9. To circumvent disturb- medium36. GAGs were precipitated and stained with
ing effects of the initial tissue processing, cartilage was Alcian Blue dye solution (Sigma). Staining was quantified
always precultured for 16–24 h in culture medium. After photometrically by the change in absorbance at 620 nm
preculture, medium was replaced by fresh culture medium (Vitalab10, Vital Science, Dieren, The Netherlands).
and cartilage samples were cultured for 4 days. Shark cartilage chondroitin sulfate (Sigma) served as a
standard. GAG release was normalized to the wet weight of
the cartilage samples36.
CARTILAGE DEGRADATION
3.0
2.5 P < 0.05
2.5
2.0
1.5
1.5
1.0
1.0
0.5
0.5 r = –0.43
n = 30
P < 0.02 0.0
Spontaneous Chondrocyte-
GAG loss mediated
0 20 40 60 80 100 degradation
Age (years)
Fig. 2. Spontaneous loss of GAGs vs chondrocyte-mediated
Fig. 1. GAG release decreases with donor age. Chondrocyte- cartilage degradation. GAG release into culture medium was
mediated release of GAGs from human femoral condyle cartilage determined as a marker for matrix degradation in cartilage of which
decreases with increasing donor age (N=30, 19–82 years). Each cellular activity was abolished by freeze-thawing (spontaneous
symbol represents the average of at least eight individually GAG loss: N=3 donors, 56±4 years; nine samples per donor) and
handled cartilage samples. in normally cultured explants (chondrocyte-mediated degradation:
N=4 donors, 55±4 years; nine samples per donor). Bars represent
mean values± S.E.M. The age did not differ between both groups
(P>0.8) Chondrocyte-mediated release of GAGs is four-fold
increased compared to the spontaneous GAG loss (P<0.05).
activity measurements were corrected for inhibition of LDH
activity as a result of glycation of LDH, using purified LDH
(Boehringer) incubated for 4 days in the presence or
absence of glucose (3, 10 and 30 mM), D(−)-ribose (3, 10
and 30 mM) or threose (3 and 10 mM) in culture medium. sizing that in the human cartilage explant culture system
GAG release is mainly (>75%) chondrocyte-mediated.
To investigate whether the age-related decrease in GAG
STATISTICAL ANALYSIS release (Fig. 1) may be caused by an increase in cartilage
AGE levels in vitro enhancement of cartilage AGE levels
Statistical evaluation was performed using SPSS soft-
was employed.
ware version 10.0 (SPSS, Chicago, IL). Data are presented
as mean± S.E.M. Correlations between AGE parameters
were determined by bivariate correlation analysis
(Pearson). Relations between cartilage AGE levels and AGE EFFECTS ON MATRIX DEGRADATION
proteoglycan synthesis or degradation were tested by Non-enzymatic glycation is initiated by many different
linear regression analysis. Differences between groups carbohydrates in vivo and results in a heterogeneous
were analyzed by Wilcoxon tests. P values less than collection of AGEs, few of which have been characterized4.
0.05 were considered to represent statistically significant To mimic this in vivo situation, different reducing sugars
differences. (glucose, ribose and threose) were used to initiate the AGE
formation in vitro. Consequently, general measures for
quantification of AGE levels (rather than a specific AGE)
Results
were employed to examine the effects of AGEs37
EFFECT OF AGING Culture of human humeral head cartilage for 4 days
resulted in the release of ∼2.5 g GAG per mg cartilage into
Chondrocyte-mediated cartilage degradation was the culture medium, in control conditions. This release was
studied in human knee cartilage of donors of various ages. decreased at increasing AGE levels, down to ∼1.0 g GAG
With increasing donor age, a significant decrease in per mg cartilage at the highest AGE levels [Fig. 3(A)–(D)].
chondrocyte-mediated GAG release was observed in All the AGE measures, absorption at 340 and 414 nm
human articular cartilage (r= −0.43, P<0.02, N=30, 19–82 [Fig. 3(A),(B)], fluorescence [Fig. 3(C)] and amino acid
years, Fig. 1). To ensure that mainly chondrocyte-mediated modification [Fig. 3(D)] showed a highly significant, nega-
cartilage degradation rather than spontaneous loss of tive linear correlation with GAG release (P<0.005 for all
GAGs was measured, cartilage degradation was compared parameters). All AGE measures showed highly significant
between cultured explants vs age-matched devitalized correlation to one another, indicating that in this study with
explants (rendered non-viable by freeze-thawing). in vitro enhancement of AGE levels, these parameters are
Chondrocyte-mediated GAG release was four-fold higher interchangeable (bivariate Pearson correlation coefficients;
than spontaneous GAG release (P<0.05, Fig. 2), empha- Table I).
Osteoarthritis and Cartilage Vol. 9, No. 8 723
3.0 3.0
A r = –0.68 B r = –0.62
P < 0.0005 P < 0.001
n = 26 n = 26
2.5 2.5
GAG release (µg/mg cartilage)
1.5 1.5
1.0 1.0
0.5 0.5
0.0 0.0
0.1 0.2 0.3 0.4 0.5 0.05 0.10 0.15 0.20
Absorption per µmol Hyp (λ: 340 nm) Absorption per µmol Hyp (λ: 414 nm)
3.0 3.0
C r = –0.77 D r = –0.74
P < 0.0001 P < 0.0001
n = 26 n = 26
2.5 2.5
GAG release (µg/mg cartilage)
2.0 2.0
1.5 1.5
1.0 1.0
0.5 0.5
0.0 0.0
10 15 20 25 30 35 40 270 260 250 240 230 220
Fluorescence (RFU/nmol Hyp) Number of Arg + Hyl + Lys
per collagen molecule
Fig. 3. Chondrocyte-mediated GAG release decreases with cartilage AGE levels. Each data point represents the mean of N=9 samples for
humeral head cartilage degradation (GAG release) and N=3 samples for AGE levels. GAG release decreases linearly with increasing AGE
levels, either determined as AGE related absorption at 340 nm (A), at 414 nm (B), fluorescence at 360/460 nm (C), or amino acid modification
(D). The correlation between matrix degradation and AGE levels is highly significant for all these AGE measures [(a)–(d); P<0.001].
Table I
Pearson correlation coefficients of in vitro enhanced AGE levels in articular cartilage (by exposure to reducing
sugars)
Amino acid Absorption at Absorption at
modification 340 nm 414 nm
Absorption at 340 nm r=0.56
[per mol hydroxyproline] P<0.005
Absorption at 414 nm r=0.66 r=0.91
[per mol hydroxyproline] P<0.0005 P<0.0001
Fluorescence at 360/460 nm r=0.46 r=0.52 r=0.48
[RFU per nmol hydroxyproline] P<0.02 P<0.01 P<0.02
All AGE measures (absorption, fluorescence and amino acid modification) show strong and highly significant
correlations.
724 J. DeGroot et al.: Glycation reduces cartilage turnover
with an AGE-dependent decrease in matrix turnover as cross-linking of type-IV collagen in lens capsules.
demonstrated in the present study, may contribute to the Biochem J 1993;296:489–96.
development of OA with increasing age. 15. Reihsner R, Menzel EJ. Two-dimensional stress-
relaxation behavior of human skin as influenced by
non-enzymatic glycation and the inhibitory agent
Acknowledgments aminoguanidine. J Biomech 1998;31:985–93.
16. Andreassen TT, Seyer-Hansen K, Bailey AJ. Thermal
This research was supported by grants from the Dutch stability, mechanical properties and reducible cross-
Arthritis Association and the Netherlands Organization for links of rat tail tendon in experimental diabetes.
Scientific Research and the Novartis Foundation for Biochim Biophys Acta 1981;677:313–7.
Gerontology. We thank the Department of Pathology 17. Mott JD, Khalifah RG, Nagase H, Shield CF, Hudson
(University Medical Center Utrecht) for providing cartilage JK, Hudson BG. Nonenzymatic glycation of type IV
samples. collagen and matrix metalloproteinase susceptibility.
Kidney Int 1997;52:1302–12.
18. Schnider SL, Kohn RR. Effects of age and diabetes
References mellitus on the solubility and nonenzymatic gluco-
sylation of human skin collagen. J Clin Invest
1. Creamer P, Hochberg MC. Osteoarthritis. Lancet 1981;67:1630–5.
1997;350:503–8. 19. Lubec G, Pollak A. Reduced susceptibility of non-
2. Felson DT, Zhang YQ. An update on the epi- enzymatically glucosylated glomerular basement
demiology of knee and hip osteoarthritis with a view membrane to proteases: is thickening of diabetic
to prevention. Arthritis Rheum 1998;41:1343–55. glomerular basement membranes due to reduced
3. Bunn HF, Higgins PJ. Reaction of monosaccharides proteolytic degradation? Ren Physiol 1980;3:4–8.
with proteins: possible evolutionary significance. 20. Melling M, Pfeiler W, Karimian-Teherani D,
Science 1981;213:222–4. Schnallinger M, Sobal G, Zangerle C, et al. Differ-
4. Reiser KM. Nonenzymatic glycation of collagen in ential scanning calorimetry, biochemical, and bio-
aging and diabetes. Proc Soc Exp Biol Med mechanical analysis of human skin from individuals
1998;218:23–37. with diabetes mellitus. Anat Rec 2000;259:327–33.
5. Reiser KM. Nonenzymatic glycation of collagen in 21. Cohen MP, Ziyadeh FN. Amadori glucose adducts
aging and diabetes. Proc Soc Exp Biol Med modulate mesangial cell growth and collagen gene
1991;196:17–29. expression. Kidney Int 1994;45:475–84.
6. Bailey AJ, Paul RG, Knott L. Mechanisms of matur- 22. Anderson SS, Wu K, Nagase H, Stettler-Stevenson
ation and ageing of collagen. Mech Ageing Dev WG, Kim Y, Tsilibary EC. Effect of matrix glycation
1998;106:1–56. on expression of type IV collagen, MMP-2, MMP-9
7. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, and TIMP-1 by human mesangial cells. Cell Adhes
Lyons TJ, et al. Effect of Collagen Turnover on the Commun 1996;4:89–101.
Accumulation of Advanced Glycation End Products. 23. Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J,
J Biol Chem 2000;275:39027–31. Schlondorff D. Nonenzymatic glycation of mesangial
8. Pokharna HK, Pottenger LA. Nonenzymatic glycation matrix and prolonged exposure of mesangial matrix
of cartilage proteoglycans: an in vivo and in vitro to elevated glucose reduces collagen synthesis and
study. Glycoconj J 1997;14:917–23. proteoglycan charge. Kidney Int 1993;43:853–64.
9. DeGroot J, Verzijl N, Bank RA, Lafeber FP, Bijlsma JW, 24. Cohen MP, Hud E, Wu VY, Ziyadeh FN. Glycated
Tekoppele JM. Age-related decrease in proteoglycan albumin modified by Amadori adducts modulates
synthesis of human articular chondrocytes: the role aortic endothelial cell biology. Mol Cell Biochem
of nonenzymatic glycation. Arthritis Rheum 1999;42: 1995;143:73–9.
1003–9. 25. Owen WFJ, Hou FF, Stuart RO, Kay J, Boyce J,
10. Bank RA, Bayliss MT, Lafeber FP, Maroudas A, Chertow GM, et al. Beta 2-microglobulin modified
Tekoppele JM. Ageing and zonal variation in post- with advanced glycation end products modulates
translational modification of collagen in normal collagen synthesis by human fibroblasts. Kidney Int
human articular cartilage. The age-related increase 1998;53:1365–73.
in non-enzymatic glycation affects biomechanical 26. Sell DR, Monnier VM. Structure elucidation of a
properties of cartilage. Biochem J 1998;330:345–51. senescence cross-link from human extracellular
11. Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe matrix. Implication of pentoses in the aging process.
SR, Baynes JW, et al. Age-related accumulation J Biol Chem 1989;264:21597–602.
of Maillard reaction products in human articular 27. Lafeber FP, VanderKraan PM, van Roy JL, Huber-
cartilage collagen. Biochem J 2000;350:381–7. Bruning O, Bijlsma JW. Articular cartilage explant
12. Monnier VM, Vishwanath V, Frank KE, Elmets CA, culture; an appropriate in vitro system to compare
Dauchot P, Kohn RR. Relation between complica- osteoarthritic and normal human cartilage. Connect
tions of type I diabetes mellitus and collagen-linked Tissue Res 1993;29:287–99.
fluorescence. N Engl J Med 1986;314:403–8. 28. Pratta MA, Tortorella MD, Arner EC. Age-related
13. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts changes in aggrecan glycosylation affect cleavage by
MS, Poitevin P, Swennen GN, et al. Breakers of aggrecanase. J Biol Chem 2000;275:39096–102.
advanced glycation end products restore large artery 29. Lee KW, Mossine V, Ortwerth BJ. The relative ability of
properties in experimental diabetes. Proc Natl Acad glucose and ascorbate to glycate and crosslink lens
Sci USA 1998;95:4630–4. proteins in vitro off. Exp Eye Res 1998;67:95–104.
14. Bailey AJ, Sims TJ, Avery NC, Miles CA. Chemistry 30. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW.
of collagen cross-links: glucose-mediated covalent Formation of pentosidine during nonenzymatic
726 J. DeGroot et al.: Glycation reduces cartilage turnover
browning of proteins by glucose. Identification of 39. Muir H. The chondrocyte, architect of cartilage. Bio-
glucose and other carbohydrates as possible mechanics, structure, function and molecular biology
precursors of pentosidine in vivo. J Biol Chem of cartilage matrix macromolecules. Bioessays 1995;
1991;266:11654–60. 17:1039–48.
31. Monnier VM, Cerami A. Nonenzymatic browning 40. Verbruggen G, Cornelissen M, Almqvist KF, Wang L,
in vivo: possible process for aging of long-lived Elewaut D, Broddelez C, et al. Influence of aging on
proteins. Science 1981;211:491–3. the synthesis and morphology of the aggrecans
32. Monnier VM, Kohn RR, Cerami A. Accelerated synthesized by differentiated human articular
age-related browning of human collagen in diabetes chondrocytes. Osteoarthritis Cartilage 2000;8:170–9.
mellitus. Proc Natl Acad Sci USA 1984;81:583–7.
41. Bayliss MT, Osborne D, Woodhouse S, Davidson C.
33. Sell DR, Monnier VM. Isolation, purification and partial
Sulfation of chondroitin sulfate in human articular
characterization of novel fluorophores from aging
human insoluble collagen-rich tissue. Connect Tissue cartilage. The effect of age, topographical position,
Res 1989;19:77–92. and zone of cartilage on tissue composition. J Biol
34. Bank RA, Beekman B, Verzijl N, De Roos JA, Sakkee Chem 1999;274:15892–900.
AN, Tekoppele JM. Sensitive fluorimetric quantitation 42. Brama PA, Tekoppele JM, Bank RA, Barneveld A, van
of pyridinium and pentosidine crosslinks in biological Weeren PR. Functional adaptation of equine articular
samples in a single high-performance liquid chroma- cartilage: the formation of regional biochemical
tographic run. J Chromatogr B Biomed Sci Appl characteristics up to age one year. Equine Vet J
1997;703:37–44. 2000;32:217–21.
35. Bank RA, Robins SP, Wijmenga C, Breslau-Siderius 43. Steinmeyer J, Knue S, Raiss RX, Pelzer I. Effects of
LJ, Bardoel AF, van der Sluijs HA, et al. Defective intermittently applied cyclic loading on proteoglycan
collagen crosslinking in bone, but not in ligament or metabolism and swelling behaviour of articular
cartilage, in Bruck syndrome: indications for a bone- cartilage explants. Osteoarthritis Cartilage 1999;7:
specific telopeptide lysyl hydroxylase on chromo- 155–64.
some 17. Proc Natl Acad Sci USA 1999;96:1054–8. 44. Mow VC, Wang CC, Hung CT. The extracellular
36. Roosendaal G, Tekoppele JM, Vianen ME, van den matrix, interstitial fluid and ions as a mechanical
Berg HM, Lafeber FP, Bijlsma JW. Blood-induced signal transducer in articular cartilage. Osteoarthritis
joint damage: a canine in vivo study. Arthritis Rheum Cartilage 1999;7:41–58.
1999;42:1033–9. 45. Homandberg GA, Meyers R, Xie DL. Fibronectin
37. Lee KW, Simpson G, Ortwerth BJ. A systematic fragments cause chondrolysis of bovine articular
approach to evaluate the modification of lens cartilage slices in culture. J Biol Chem 1992;267:
proteins by glycation-induced crosslinking. Biochim 3597–604.
Biophys Acta 1999;1453:141–51. 46. Poole AR. Imbalances of anabolism and catabolism
38. Girton TS, Oegema TR, Tranquillo RT. Exploiting gly- of cartilage matrix components in osteoarthritis.
cation to stiffen and strengthen tissue equivalents for In: Kuettner KE, Goldberg VM, Eds. Osteoarthritic
tissue engineering. J Biomed Mater Res 1999;46: disorders. Rosemont: American Academy of
87–92. Orthopaedic Surgeons 1995:247–260.